Biotech The Galien Foundation Announces 2024 Prix Galien USA Nominees for “Best Biotechnology Product,” “Best Pharmaceutical Product” and “Best Product for Rare/Orphan Diseases” August 16, 2024
Biotech Foresee Pharmaceuticals Announces Several New Developments Related to its SIF Long-Acting Injectable (LAI) Technologies – Solidifying its Position as a Leader in Complex Long-Acting Injectable Products August 16, 2024
Biotech First patient enrollment in the U.S. – A milestone for the global multi-center phase Ⅲ clinical trial of telitacicept for myasthenia gravis August 12, 2024
Biotech Regenerative Medicine Market to Reach $531.7 Billion, Globally, by 2033 at 32.4% CAGR: Allied Market Research August 12, 2024
Biotech Bispecific Antibodies For Cancer Market size is set to grow by USD 314.3 million from 2024-2028, Increasing prevalence of cancer to boost the market growth, Technavio August 12, 2024
Featured News New Study Reveals How Classical Music Could Revolutionize Depression Care August 12, 2024
Featured News Alzamend Neuro Partners with Massachusetts General Hospital for Phase II Trial of Next-Generation Treatment for Major Depressive Disorder August 12, 2024
Biotech Alzamend Neuro Partners with Massachusetts General Hospital for a Phase II Clinical Trial of AL001, a Next‑Generation Lithium Therapeutic Drug Candidate, involving Patients with Major Depressive Disorder August 12, 2024
Biotech IDEAYA Biosciences, Inc. Reports Second Quarter 2024 Financial Results and Provides Business Update August 9, 2024
Biotech Rowers Complete Record-breaking 2,800-mile Open Ocean Row to Benefit Michael J. Fox Foundation, Increase Fundraising Goal to $41 Million August 8, 2024